Takeda logo

Takeda Oncology's R&D Approach: Advancing Immuno-Oncology through Innate Immunity | Takeda Oncology

Science and Research

Our R&D Approach

image alt text

Our research and development is building on our demonstrated leadership in oncology by advancing a cutting-edge pipeline focused on the power of innate immunity.

The innate immune system is an arm of the immune system that serves as the body’s first defense mechanism against disease. As most immunotherapies focus on leveraging the adaptive arm of the immune system, the potential of the innate immune system has been historically underexplored in cancer research.

In collaboration with a network of world-class partners, we are exploring opportunities to introduce new classes of immunotherapies that enhance innate immunity and deploy both arms of the immune system to produce deep, durable responses for patients with solid tumors and / or blood cancers.

Learn more about the scientific platforms we’re exploring that leverage the immune system, with a focus on innate immunity.

Explore More

Card image
Harnessing the power of the immune system to fight cancer.
Card image
We believe the best way to achieve our aspiration to cure cancer is by working together.
Keep up on the latest Oncology news by visiting our newsroom.

All trademarks are the property of their respective owners.

©2024 Takeda Pharmaceuticals U.S.A., Inc.

All rights reserved.   01/23